- PLN31.71m
- PLN26.47m
- PLN23.01m
- 92
- 29
- 20
- 41
Annual balance sheet for Genomed SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | PAS | PAS | PAS | PAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.48 | 4.92 | 3.49 | 5.26 | 5.24 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.19 | 1.27 | 1.46 | 1.79 | 1.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 7.35 | 7.59 | 7.26 | 9.42 | 9.19 |
| Net Property, Plant And Equipment | 2.44 | 2.17 | 1.7 | 1.2 | 2.13 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 10 | 10.3 | 10.4 | 12.1 | 12.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.63 | 1.48 | 1.2 | 1.97 | 1.46 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.45 | 1.53 | 1.24 | 2.06 | 1.8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 7.56 | 8.8 | 9.13 | 10.1 | 11 |
| Total Liabilities & Shareholders' Equity | 10 | 10.3 | 10.4 | 12.1 | 12.8 |
| Total Common Shares Outstanding |